CH395140A - Procédé de préparation de nouveaux dérivés de l'acétanilide - Google Patents

Procédé de préparation de nouveaux dérivés de l'acétanilide

Info

Publication number
CH395140A
CH395140A CH1236764A CH1236764A CH395140A CH 395140 A CH395140 A CH 395140A CH 1236764 A CH1236764 A CH 1236764A CH 1236764 A CH1236764 A CH 1236764A CH 395140 A CH395140 A CH 395140A
Authority
CH
Switzerland
Prior art keywords
radical
carbon atoms
phenyl
methylamido
dichloracet
Prior art date
Application number
CH1236764A
Other languages
English (en)
Inventor
Oxley Peter
William Bristow Norman
Rosindale Housley John
Woolfe Gerald
Charles Wilmshurst Eric
Fraser James
Harrison Williams Georg Alfred
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Publication of CH395140A publication Critical patent/CH395140A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/73—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by amino or imino, or substituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description


  
 



  Procédé de préparation de nouveaux dérivés de   l'acétanilide   
 La présente invention a pour objet un procédé de préparation de nouveaux dérivés de   l'acétanilide    thérapeutiquement utiles, répondant à la formule:
EMI1.1     
 dans laquelle R' représente un radical alcoyle d'au moins 4 atomes de carbone, alcényle d'au moins 4 atomes de carbone, aryle (à l'exception du radical phényle non substitué),   aralcoyle,    aralcényle, alcoxyalcoyle, un radical cycloaliphatique, aryloxyalcoyle, aryloxyalcényle, aryloxyaryle, un radical hétérocyclique, hétérocycloalcoyle, hétérocycloalcényle ou le radical   - R2    -   COOR    dans lequel   R    est un reste alcoylène, arylène, cycloalcoylène, arylène-dioxydialcoyle,

   ou un noyau hétérocyclique disubstitué et   R9    est le radical   4(didhloracét-N-méthylarnido)    phényle, le radical   R' pouvant    porter un ou plusieurs substituants halo, nitro, amino, acylamino, alcoyle, alcoxy, acyle et méthanesulfonyle.



   Les composés répondant à la formule générale ci-dessus se sont montrés doués de propriétés intéressantes en tant qu'amibicides.



   Le procédé selon l'invention est caractérisé en ce que   l'on    fait réagir du sulfite de 4-dichloracét  N-méthylanaidophényle    avec un acide de formule générale R4COOH dans laquelle R4 représente un radical alcoyle d'au moins 4 atomes de carbone, un radical alcényle d'au moins 4 atomes de carbone, un radical aryle à l'exception du radical phényle non substitué, un radical aralcoyle, aralcényle, alcoxyalcoyle, cycloaliphatique, aryloxyalcoyle, aryloxyalcényle, aryloxyaryle, un groupe hétérocyclique, hétérocycloalcoyle, hétérocycloalcényle ou le groupe   -R2-COOH    dans lequel R2 est tel que défini cidessus, la réaction étant e±fectuée en présence d'un agent de fixation d'acide.



   L'activité amibicide des composés de formule générale I ci-dessus a été démontrée sur les animaux de la façon suivante: La   technique    est en   substance    oelle décrite par   Jones      (Annals    of Tropical Medicine and Parasitology, 1946, 40, 130). Elle consiste à inoculer des trophozoides de E. hystolytica dans le   c cum    de rats récemment sevrés. Dès le jour suivant l'inoculation, on administre par tube stomacal cinq doses quotidiennes du médicament essayé à chaque individu d'un groupe de rats et on sacrifie les animaux un jour après la dose finale. On examine le   c cum    de chaque rat microscopiquement et macros  copiquement    et on évalue le degré d'infection des rats selon une échelle arbitraire.

   Le degré moyen d'infection (  D.M.I.  ) est alors calculé pour chaque groupe. On considère un composé comme présentant une activité amibicide prometteuse lorsque le  D.M.I.   du groupe traité est inférieur à la moitié de celui d'un groupe témoin non traité. Avec des médicaments à haute activité, les rats sont complètement débarrassés des amibes et le   D.M.I.   est nul.



  Les tests initiaux d'orientation ont montré que le groupe préféré de composés comprend les esters du   4-hydroxy-dichloracét-N-méthylanilide    avec des acides carboxyliques contenant un noyau hétérocyclique ou un groupe aryloxy, par exemple le fu   roate de 4-hydroxy-dichloracét-N-méthylanilide; ; une    comparaison directe a montré que ce dernier est approximativement quatre fois plus actif que le 4  hydroxy-dichloracét-N-méthylanilide    et deux fois  plus actif que le   4-b enzoyloxy-N-méthyl-dichloracé-    tanilide.



   Du point de vue clinique, l'amibiase existe tant sous la forme aiguë que sous la forme chronique, et seule la forme chronique a été combattue par le 4  hydroxy-dichloracét-N-méthyl-anilide    et les esters décrits dans les brevets britanniques Nos 767148 et 794762. On a découvert maintenant que le membre du groupe préféré de composés de formule générale I ci-dessus qui a été choisi pour les essais cliniques, soit le 2-furoate de   4-hydroxy-dichloracét-N-méthyl-    anilide, présente non seulement une activité accrue contre l'amibiase chronique, mais se montre également actif contre la forme aiguë de la maladie, qui peut être complètement guérie par administration de fuorate de   4'hydroxy-dichloracét-N-méthylanilide    à la dose de 20 mg/kg/jour pendant 10 jours.

   La dose totale peut varier à partir de 15 mg/kg/jour, et est de préférence de 20-40 mg/kg/jour. Cette dose peut être présentée sous forme d'unités pouvant contenir de 100 à 1000 mg de produit actif, les unités étant administrées de préférence en doses divisées tout le long du jour, par exemple en trois ou quatre fois par jour.



   Exemple
 Pour préparer le   4-chlorobenzoate    de   4-(dichlor-    acét-N-méthylamido)-phényle, on ajoute   2,56 g    d'acide   4-chlorobenzo ; que    à une solution agitée de 8,4 g de sulfite de   4-(dichloracét-N-méthylamido)-phényle    dans 15 ml de pyridine. Après avoir laissé reposer durant 18 heures à 200 C, on coule la solution résultante dans un mélange de 100ml d'hydroxyde de sodium N, 25 g de glace et 0,1 g d'hydrosulfite de sodium. On recueille par filtration le solide précipité, on le lave à l'eau et on le sèche et on obtient ainsi le 4-chlorobenzoate de   4¯ (dichloracét-N-mé-      thylamido)-phényle    sous forme d'un solide cristallin fondant à   96-98,50    C.



   Pour préparer le sulfite de   4-(dichloracét-N-mé-    thylamido)-phényle, on ajoute goutte à goutte une solution de 16,6   ml    de triéthylamine dans   50 ml    de tétrahydrofuran à une solution glacée et agitée de   23, 4 g    de   4-(dichloracét-N-méthylamido)-phénol    et 6,0 g de chlorure de thionyle dans 85 mi de tétrahydrofuran à une vitesse telle que la température se maintienne entre 6 et   10o C.    On agite ensuite le   mélange durant 45 minutes à 20u C et, après filtra-    tion, on l'évapore sous pression réduite et on obtient le sulfite de   4-(dichloracét-N-méthylamido)-phényle    sous forme d'une gomme.

Claims (1)

  1. REVENDICATION Procédé de préparation d'un composé de formule générale: EMI2.1 dans laquelle R' représente un radical alcoyle d'au moins 4 atomes de carbone, alcényle d'au moins 4 atomes de carbone, aryle à l'exception du radical phényle non substitué, aralcoyle, aralcényle, alcoxyalcoyle, un radical cycloaliphatique, aryloxyalcoyle, aryloxyalcényle, aryloxyaryle, un radical hétérocyclique, hétérocycloalcoyle, hétérocycloalcényle ou le radical-R'COOR3 dans lequel R- est un reste alcoylène, arylène, cycloalcoylène, arylène-dioxydialcoyle, ou un noyau hétérocyclique disubstitué et R3 est le radical 4-(dichloracét-N-méthylamido)-phényle, le radical R' pouvant porter un ou plusieurs substituants halo, nitro, amino, acylamino, alcoyle, alcoxy, acyle et méthanesulfonyle,
    caractérisé en ce que l'on fait réagir du sulfite de 4-dichloracét-N-méthylamido phényle avec un acide de formule générale R4COOH dans laquelle R4 représente un radical alcoyle d'au moins 4 atomes de carbone, un radical alcényle d'au moins 4 atomes de carbone, un radical aryle à l'exception du radical phényle non substitué, un radical aralcoyle, aralcényle, alcoxyalcoyle, cycloaliplhatique, aryloxyalcoyle, aryloxyalcényle, aryloxyaryle, un groupe hétérocyclique, hétérocycloalcoyle, hétérocycloalcényle ou le groupe R-COOH dans lequel R2 est tel que défini ci-dessus, la réaction étant effectuée en présence d'un agent de fixation d'acide.
    SOUS-REVENDICATION Procédé selon la revendication, caractérisé en ce que l'on fait réagir de l'acide 4-chloro-benzoique avec du sulfite de 4-dichloracét-N-méthylamido-phé- nyle en présence de pyridine.
CH1236764A 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide CH395140A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB14460/58A GB855556A (en) 1958-05-06 1958-05-06 New acetanilide derivatives
GB1786758 1958-06-04

Publications (1)

Publication Number Publication Date
CH395140A true CH395140A (fr) 1965-07-15

Family

ID=26250582

Family Applications (4)

Application Number Title Priority Date Filing Date
CH1236664A CH407161A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide
CH1236764A CH395140A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide
CH7294759A CH393364A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide
CH1236564A CH407160A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1236664A CH407161A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH7294759A CH393364A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide
CH1236564A CH407160A (fr) 1958-05-06 1959-05-06 Procédé de préparation de nouveaux dérivés de l'acétanilide

Country Status (6)

Country Link
US (1) US3028386A (fr)
BR (1) BR5909907D0 (fr)
CH (4) CH407161A (fr)
DE (1) DE1418479A1 (fr)
FR (1) FR436M (fr)
GB (1) GB855556A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1101747A (en) * 1964-04-09 1968-01-31 Sterwin Ag Salicylamide derivatives
US4288605A (en) * 1969-03-12 1981-09-08 Stauffer Chemical Company Cyclohexane carbonyloxybromoacetanilide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2912438A (en) * 1954-07-22 1959-11-10 Boots Pure Drug Co Ltd New acetanilides derivatives and the manufacture thereof
GB767149A (en) * 1954-07-27 1957-01-30 English Electric Co Ltd Improvements in and relating to control apparatus for electric mine hoists and the like
NL96977C (fr) * 1955-11-03

Also Published As

Publication number Publication date
CH407161A (fr) 1966-02-15
BR5909907D0 (pt) 1973-05-17
FR436M (fr) 1961-04-24
CH393364A (fr) 1965-06-15
CH407160A (fr) 1966-02-15
DE1418479A1 (de) 1968-10-10
GB855556A (en) 1960-12-07
US3028386A (en) 1962-04-03

Similar Documents

Publication Publication Date Title
CA2036876C (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0506532A1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
EP0061386B1 (fr) Acides ((2-oxo-3-tétrahydrothiénylcarbamoyl)-alkylthio) acétiques, leurs sels et leurs esters, leur procédé de préparation et les compositions pharmaceutiques en contenant
EP0646578B1 (fr) Phényl carboxamides isoxazoles et leurs sels, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
JPS60156653A (ja) β−フエネタノ−ルアミン誘導体
CH395140A (fr) Procédé de préparation de nouveaux dérivés de l'acétanilide
FR2465710A1 (fr) Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant
EP0001947B1 (fr) Dérivés de l'amino-2 thiazoline, procédé de préparation et compositions pharmaceutiques les contenant
FR2597865A1 (fr) Nouveaux derives d'un acide benzyl alkyl carboxylique substitue par un radical 4-pyridinyl aminocarbonyle, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
CA2161284C (fr) Nouvelles o-arylmethyl n-(thio)acyl hydroxylamines, leurs procedes de preparation et les compisitions pharmaceutiques qui les contiennent
CH615673A5 (fr)
EP0035945B1 (fr) Nouvelles guanidines acylées, urées et urées substituées, leur procédé de fabrication et leur application en tant que médicaments
JPH02275846A (ja) カルボン酸誘導体
EP0168309B1 (fr) Nouveaux dérivés de l'isoxazoloquinoléinone, procédé et intermédiaires de préparation, application à titre de médicaments, et compositions les renfermant
EP0082040B1 (fr) Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
EP0256909A1 (fr) Acide N,N-bis-(4-fluorophényl) carbamoylacétohydroxamique et composition pharmaceutique le contenant
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
US3161649A (en) Substituted benzoxazoles
CA1106376A (fr) Procede de preparation de nouveaux esters anthraniliques
CH427801A (fr) Procédé de préparation de dérivés du succinimide
EP0283362A1 (fr) 2-(benzhydrylsulfonyl) acétamide, son procédé de préparation et son application en thérapeutique
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
EP0081418A1 (fr) Dérivés oxygènes de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
JPS6033088B2 (ja) 脂質低下剤